The article reports on the study conducted by Norman Sharpless of the University of North Carolina, Chapel Hill, and his coworkers that evaluates the effectiveness of p16Ink4a gene in detecting internal cancers. It observes that p16Ink4a-Luc lit up breast, skin and blood cell malignancies, as well as spontaneous tumors. It suggests that average cellular age does not predict the propensity for cancer.